EUROPEAN JOURNAL OF DERMATOLOGY欧洲皮肤病学杂志

EUROPEAN JOURNAL OF DERMATOLOGY(英文缩写 EUR J DERMATOL),ISSN 1167-1122,eISSN 1952-4013,中文译名:欧洲皮肤病学杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
1.900
JCR 分区
Q3
CAS 分区
B4
近一年发文量
194
本站 PubMed 收录统计

发文量统计区间:2025-09-27 至 2026-09-27,按本站收录文献的发表日期统计。

ISSN: 1167-1122 · eISSN: 1952-4013 · 缩写: EUR J DERMATOL ·中文: 欧洲皮肤病学杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《欧洲皮肤病学杂志》是面向临床与科研皮肤科医师的综合性期刊,关注皮肤病的诊断、治疗与病理机制。内容涵盖炎症性皮肤病、皮肤肿瘤、感染性皮肤病及皮肤外科等方向,兼顾欧洲及国际读者的临床实践需求。该刊注重临床病例与转化研究的结合,适合希望了解皮肤病学前沿进展并获取实用诊疗信息的专科医生和研究人员阅读。

研究方向

主要发表皮肤病学领域的临床研究、病例报告、综述及治疗经验,涉及银屑病、湿疹、皮肤肿瘤、自身免疫性皮肤病、感染与皮肤外科等主题。论文类型包括原创研究、短篇报告、综述和读者来信,强调临床观察与病理机制的结合。

期刊特色

研究取向偏重临床实用性与病例积累,论文常以真实诊疗数据或典型病例为基础,突出对皮肤科日常实践的参考价值。适合临床皮肤科医师、住院医师及关注皮肤病诊疗进展的研究人员阅读与投稿。

投稿难度

投稿难度中等偏上,对临床资料的完整性和病例的典型性要求较高。建议准备时突出研究的临床意义,完善随访与病理证据,并注意英文表达的规范性。该刊对创新性要求相对温和,但需避免单纯重复已有结论。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20212.805Q2
20222.500Q2
20232.000Q3
20241.500Q3
20251.900Q3

EUROPEAN JOURNAL OF DERMATOLOGY 最新收录文献

  1. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    1. HPV-16-positive squamous cell carcinoma in situ of the upper lip.

    作者:
    Yuri Soma, Shinpei Miura, Kazushi Anzawa, Akira Shimizu, Hiroo Amano
    日期:
    2026-09-21

    该文献暂无摘要。

  2. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    2. Prominent intralesional vascularity on Doppler ultrasound in a Wnt/β-catenin-activated nonpilomatrical carcinoma of the skin.

    作者:
    Masashi Iwata, Kazuyasu Fujii, Megumi Aoki, Keisuke Goto, Shigeto Matsushita
    日期:
    2026-09-21

    该文献暂无摘要。

  3. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    3. Bimekizumab-associated eyelid dermatitis in psoriasis: a real-world clinical case series.

    作者:
    Carlos Llamas-Segura, Francisco José Navarro-Triviño, Marta Cebolla-Verdugo, Ricardo Ruiz-Villaverde
    日期:
    2026-09-20

    该文献暂无摘要。

  4. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    4. Binary dermoscopic classification inadequately stratifies urgent and convenience excision decisions in community dermatology practice.

    作者:
    Calogero Pagliarello, Davide Geat, Carlo Renè Girardelli
    日期:
    2026-09-20

    Dermoscopy is traditionally framed as a binary benign-malignant tool. Yet real-world practice uses multi-level triage: dermatologists allocate lesions to urgent excision, non-urgent excision, or surveillance based on dermoscopic atypia, contextual factors, and surveillance feasibility. Convenience excisions -low-suspicion lesions removed when monitoring is impractical - are a common, unacknowledged pattern. Dermoscopic literature reports only binary outcomes, ignoring this process. To evaluate whether clinical urgency classification captures melanoma risk beyond isolated dermoscopic assessment in community practice with limited surveillance capacity. We retrospectively analysed 371 consecutively excised melanocytic lesions. Two blinded dermatologists independently assigned four-level gestalt atypia scores. Referring dermatologists prospectively classified excisions as urgent or non-urgent, integrating morphological concern with surveillance constraints. Histopathology identified melanoma prevalence and number needed to excise (NNE). Multivariable regression evaluated predictors of melanoma. Melanoma prevalence was 23.2% (86 melanomas: 41 in situ, 45 invasive; NNE=4.3). Inter-rater agreement for morphology-only assessment was poor (κ=0.16), with weak histopathological correlation (ρ=0.23-0.29). Most excisions (75%) were non-urgent, predominantly convenience excisions, yet captured 44 of 86 melanomas (51%). For invasive melanoma alone, NNE rose to 8.2, still favourable versus the 1:10 benchmark. Age predicted melanoma-in situ diagnoses, but age-stratified analysis showed no disproportionate overdiagnosis. Clinical urgency -which integrates morphological concern with contextual factors and shares information with dermoscopic assessment- predicted melanoma (OR=3.05, p=0.002) beyond gestalt scores, age, and phenotypic complexity. Binary dermoscopic frameworks inadequately reflect real-world multi-factorial triage. Effective melanoma detection depends on integrating morphology with patient-specific risk and system-level factors beyond dermoscopy alone.

  5. JCR分区: Q3 CAS分区: B4 影响因子: 1.9
  6. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    6. Routine blood biomarkers associated with clinical response to tralokinumab in patients with atopic dermatitis: a 48-week real-world study in Japan.

    作者:
    Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama, Hidehisa Saeki, Eita Fujimoto, Sei-Ichiro Motegi, Naoko Kanda
    日期:
    2026-09-05

    Tralokinumab is effective for atopic dermatitis (AD), however, biomarkers reflecting its therapeutic effects have not been fully established. To evaluate whether blood biomarkers are associated with clinical response to tralokinumab during 48 weeks of treatment for AD. We conducted a prospective two-centre observational study of 203 patients with moderate-to-severe AD treated with tralokinumab between October 2023 and October 2025. Eczema Area and Severity Index (EASI) and Peak Pruritus-Numerical Rating Scale (PP-NRS) were evaluated at weeks 0, 4, 12, 16, 24, 36, and 48. Serum immunoglobulin E (IgE), thymus and activation-regulated chemokine (TARC), lactate dehydrogenase (LDH), and total eosinophil count were evaluated simultaneously. Percent reduction of TARC correlated with decreased EASI and PP-NRS at weeks 4 and 12. Percent reduction of IgE correlated with decreased EASI at weeks 4 and 12 and decreased PP-NRS at week 4. Percent reduction of LDH correlated with decreased EASI at weeks 4, 12, and 24, whereas a correlation with PP-NRS was significant only at week 4. The level of TARC may reflect the early therapeutic effects of tralokinumab on both clinical signs and pruritus in patients with AD. IgE may also reflect early treatment response, particularly for clinical signs, whereas LDH may reflect early and mid-term improvement of clinical signs.

  7. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    7. Ambient temperature and palmoplantar pustulosis exacerbation-related healthcare visits: a 20-year observational cohort.

    作者:
    Sijie Ma, Jiaqi Wang, Zhongrui Xu, Jingyu Du, Wenyao Chen, Biqing Tian, Xiaohua Wang, Bin Yang, Gang Wang, Shuai Shao
    日期:
    2026-09-03

    Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disease marked by recurrent pustules and erythema on the palms and soles. Whether ambient temperature is associated with PPP activity remains insufficiently defined. To evaluate the association between ambient temperature and PPP exacerbation-related healthcare visits. We conducted a 20-year retrospective observational study including 3,834 patients with dermatologist-diagnosed PPP treated between January 2004 and December 2024. Clinical visit data were linked to historical meteorological records according to patients' residential region and visit month. The primary outcome was defined as PPP exacerbation-related healthcare visits, an operational visit-based proxy for clinically active or suspected active PPP. Skin biopsy was performed in 47.4% (n=1,818) of patients. PPP outpatient visits and the proportion of PPP cases among all psoriasis patients peaked during summer. Compared with a simulated random distribution stratified by year and geographic region, the month of PPP exacerbation-related healthcare visits showed a shift toward higher ambient temperatures. In rank-based analyses, 47.9% (n=1,768) of visits occurred in the hottest month relative to the preceding three months. In addition, 58.6% of patients experienced an increase in ambient temperature before the PPP-related visit. Sensitivity analyses restricted to records suggestive of recurrence, progression, or treatment failure showed generally consistent temperature-related patterns. Elevated ambient temperature was associated with PPP exacerbation-related healthcare visits. These findings should be interpreted as associations rather than evidence of causality and require confirmation in prospectively defined PPP cohorts.

  8. JCR分区: Q3 CAS分区: B4 影响因子: 1.9
  9. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

    9. PTPN11 variants in four Chinese patients: a case series and genotype-phenotype analysis.

    作者:
    Piaoping Zhao, Qin Zeng, Qiaoyu Cao, Rui Lei, Haisheng Huang, Qin Yan, Feng Tian, Ming Li
    日期:
    2026-08-31

    Noonan syndrome (NS) and LEOPARD syndrome (LS) are well-characterized RAS/MAPK pathway-related disorders with strong genotype-phenotype correlations. Most cases of both syndromes are caused by variants in the PTPN11 gene, with specific sites predisposing to either NS or LS. The association between PTPN11 and granular cell tumours (GCTs) remains largely unexplored. To further investigate the phenotypic spectrum of patients with PTPN11 variants. We performed whole-exome sequencing on four Chinese children who presented with café-au-lait macules as the initial cutaneous manifestation. To confirm the mutation, Sanger sequencing was performed on DNA samples obtained from the patient and both parents. Histopathological examination and immunohistochemical staining were performed on a subcutaneous nodule from patient 1 to characterize the lesion. Three PTPN11 variants were identified: c.1391G>C (p. Gly464Ala), c.1403C>T (p. Thr468Met), and c.1493G>T (p. Arg498Leu). Notably, patient 1, who carried the PTPN11 c.1391G>C variant, presented with coexisting granular cell tumours -an association that has not previously been reported for this specific variant. The association with granular cell tumours highlights the clinical importance of long-term surveillance of neural crest-derived neoplasms in PTPN11 variant carriers and broadens our understanding of the diverse phenotypic outcomes associated with PTPN11 variants.

  10. JCR分区: Q3 CAS分区: B4 影响因子: 1.9

在 EUROPEAN JOURNAL OF DERMATOLOGY 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊